Abstract
ATTEMPTS to develop long-term suspension cultures of human myeloid leukaemic cells have met with limited success. Lymphoblastoid lines carrying the Epstein–Barr virus genome occasionally arise during such attempts but these lymphoid cells originate from contaminating B lymphocytes and not from the leukaemic myeloid cells1. A line established from the pleural fluid of a patient with chronic myeloid leukaemia in blast crisis2 (designated K-562) has no B-cell or T-cell markers3–4 and does not seem to be of lymphoid origin4. Its lack of morphological and histochemical differentiation2–4, however, makes it difficult to determine whether these cells are derived from myeloblasts or more primitive stem cells4. Another less documented cell line (8261) derived from the peripheral blood of a patient with acute myelogenous leukaemia showed apparent morphological and functional differentiation in agar in the presence of a feeder layer of peripheral blood leukocytes but did not differentiate in suspension culture5. Our laboratory previously reported that cultures of differentiating myeloid leukaemic cells can be maintained for several months in suspension culture but only when enriched with conditioned media (CM) from certain monolayer fibroblastic cultures of first trimester whole human embryos (ref. 6 and Ruscetti et al. in preparation). We describe here for the first time the derivation from myeloid leukaemic cells of a leukocyte culture that by morphological and histochemical criteria clearly and persistently differentiates along the myeloid series without an exogenous source of conditioned medium.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nilsson, K. & Pontén, J. Int. J. Cancer 15, 321–341 (1975).
Lozzio, C. B. & Lozzio, B. B. Blood 45, 321–334 (1975).
Klein, E. et al. Int. J. Cancer 18 421–431 (1976).
Lozzio, C. B., Lozzio, B. B., Yang, W-K, Ichiki, A. T. & Bamberger, E. G. Cancer Res. 36, 4657–4662 (1976).
Barak, Y., Shore, N. A., Higgins, G. R. & Vadakan, V. V. Br. J. Haemat. 27, 543–549 (1974).
Gallagher, R. E., Salahuddin, S., Hall, W. T., McCredie, K. B. & Gallo, R. C. Proc. natn. Acad. Sci. U.S.A. 72, 4137–4141 (1975).
Hayflick, L. Texas Rep. Biol. Med. 23, 285–303 (1965).
Bernard, J., Lasneret, J., Chome, J., Levy, J. P. & Boiron, M. J. clin. Path. 16, 319–324 (1963).
Yam, L. T., Li, C. Y. & Crosby, W. H. Am. J. clin. Path. 55, 283–290 (1971).
Williams, W. J. in Hematology (eds Williams, W. J. et al.) 1395 (McGraw Hill, New York, 1972).
Williams, W. J. in Hematology (eds Williams, W. J. et al.) 1393 (McGraw Hill, New York, 1972).
Lay, W. H., Mendes, N. F., Bianco, C. & Nussenzweig, V. Nature 230, 531–532 (1971).
Jondal, M., Holm, G. & Wigzell, H. J. exp. Med. 136, 207–215 (1972).
Reedman, B. M. & Klein, G. Int. J. Cancer 11, 499–520 (1973).
LoBue, J., Dornfest, B. S., Gordon, A. S., Hurst, J. & Quastler, H. Proc. Soc. exp. Biol. Med. 112, 1058–1062 (1963).
Moore, M. A. S. in Recent Advances in Cancer Research: Cell Biology, Molecular Biology and Tumor Virology (ed. Gallo, R. C.) (CRC, Cleveland, Ohio, in the press).
Fibach, E. & Sachs, L. J. Cell Physiol. 86, 221–230 (1975).
Ichikawa, Y. J. Cell Physiol. 74, 223–234 (1969).
Moore, M. A. S., Spitzer, G., Williams, N., Metcalf, D. & Buckley, J. Blood 44, 1–18 (1974).
Krystosek, A. & Sachs, L. Cell 9, 675–684 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
COLLINS, S., GALLO, R. & GALLAGHER, R. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270, 347–349 (1977). https://doi.org/10.1038/270347a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/270347a0
This article is cited by
-
Whole-genome screens reveal regulators of differentiation state and context-dependent migration in human neutrophils
Nature Communications (2023)
-
Caspase-2 is a mediator of apoptotic signaling in response to gemtuzumab ozogamicin in acute myeloid leukemia
Cell Death Discovery (2022)
-
Multi-omics reveals mitochondrial metabolism proteins susceptible for drug discovery in AML
Leukemia (2022)
-
Apoptotic and antioxidant effects in HCT-116 colorectal carcinoma cells by a spiro-acridine compound, AMTAC-06
Pharmacological Reports (2022)
-
Pattern recognition in lymphoid malignancies using CytoGPS and Mercator
BMC Bioinformatics (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.